相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial
Elvira Isganaitis et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
Richard M Bergenstal et al.
LANCET (2021)
Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures
Maria G. Thomas et al.
DIABETES OBESITY & METABOLISM (2021)
Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study
Jan Soupal et al.
DIABETES CARE (2020)
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial
Sue A. Brown et al.
DIABETES CARE (2020)
Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial
Ronnie Aronson et al.
Lancet Diabetes & Endocrinology (2020)
Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study
Harold W. de Valk et al.
DIABETES THERAPY (2020)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Insulin Pumps: Review of Technological Advancement in Diabetes Management
Nicoleta D. Sora et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)
Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study
Gian Paolo Fadini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018
Nicole C. Foster et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials
Xiao-Wen Zhang et al.
ACTA DIABETOLOGICA (2018)
Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study
Fiona M. Campbell et al.
PEDIATRIC DIABETES (2018)
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial
Marcus Lind et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial
Roy W. Beck et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes
Grazia Aleppo et al.
DIABETES CARE (2017)
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
Satish K. Garg et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2017)
A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance
Hanne Haahr et al.
CLINICAL PHARMACOKINETICS (2014)
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY INSULIN PUMP MANAGEMENT TASK FORCE
George Grunberger et al.
ENDOCRINE PRACTICE (2014)
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
R. E. Ratner et al.
DIABETES OBESITY & METABOLISM (2013)
Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device)
Meryl Brod et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2009)
Hypoglycemia with Intensive Insulin Therapy: A Systematic Review and Meta-Analyses of Randomized Trials of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections
Mitra M. Fatourechi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine
D. Bruttomesso et al.
DIABETIC MEDICINE (2008)
分享论文
